Amit Kumar
AstraZeneca Pharma India Limited, Medical Department, Block N1,
12th Floor, Manyata Embassy Business Park, Rechenahalli, Outer Ring Road, Bangalore-560045
India
Research Article
Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Mellitus Patients: START-India Study
Author(s): Rajesh Rajput, K M Prasanna Kumar, Krishna Seshadri, Pankaj Agarwal, Pradeep Talwalkar, Bhavesh Kotak, Ammar Raza, Hardik Vasnawala and Amit KumarRajesh Rajput, K M Prasanna Kumar, Krishna Seshadri, Pankaj Agarwal, Pradeep Talwalkar, Bhavesh Kotak, Ammar Raza, Hardik Vasnawala and Amit Kumar
Objective: Despite rising incidence of diabetes in India, we currently lack country wide data on the prevalence of CKD in T2DM patients. Hence this nationwide study was planned. Methods: This was a nationwide, cross-sectional, observational, multi-centric study to assess prevalence of CKD among T2DM patients. The primary endpoint of the study was to estimate proportion of T2DM patients with CKD (glomerular filtration rate [GFR] <60 ml/min/1.73 m2or albumin creatinine ratio [ACR] ≥ 30 mg/g or ≥ 3 mg/mmol or both). The blood/plasma and urine samples, were collected for estimation of hemoglobin A1c, microalbuminuria, serum creatinine, urine creatinine, and routine urine analysis. Results: Of the 3043 screened subjects, 3000 eligible subjects were enrolled, out of which 46% were females. The mean age was 53.4 (± 11.9) years, with a mean body mass index of 27.3 (± 4... View More»
